Works matching AU Hosomi, Yukio

Results: 101
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 4, p. 389, doi. 10.1016/j.cllc.2024.02.002
    By:
    • Yusuke Okuma;
    • Shogo Nomura;
    • Jun Sakakibara-Konishi;
    • Yoko Tsukita;
    • Shuji Murakami;
    • Yukio Hosomi;
    • Yuichi Tambo;
    • Yoshihito Kogure;
    • Hiroshige Yoshioka;
    • Motohiro Tamiya;
    • Kiichiro Ninomiya;
    • Eiji Iwama
    Publication type:
    Article
    10

    A Phase II Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung Cancer: TORG2241 (UBE-Q).

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 1, p. 85, doi. 10.1016/j.cllc.2023.09.006
    By:
    • Shinji Nakamichi;
    • Kaoru Kubota;
    • Kotone Matsuyama;
    • Toshihiro Misumi;
    • Toshiyuki Kozuki;
    • Shunichi Sugawara;
    • Katsuhiko Naoki;
    • Nobuaki Kobayashi;
    • Takehito Shukuya;
    • Tsuneo Shimokawa;
    • Masashi Ishihara;
    • Hiroshi Wakui;
    • Yukio Hosomi;
    • Hiroshi Tanaka;
    • Haruhiro Saito;
    • Shinobu Hosokawa;
    • Yuichi Takiguchi;
    • Takashi Kasai;
    • Hiroshi Nokihara;
    • Ryo Morita
    Publication type:
    Article
    11

    A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non--Small Cell Lung Cancer Study: (NEJ048A/NEXUS).

    Published in:
    Clinical Lung Cancer, 2023, v. 24, n. 4, p. 371, doi. 10.1016/j.cllc.2023.01.008
    By:
    • Akihiko Miyanaga;
    • Hajime Asahina;
    • Satoshi Watanabe;
    • Takehito Shukuya;
    • Yukari Tsubata;
    • Yukio Hosomi;
    • Shunichi Sugawara;
    • Makoto Maemondo;
    • Tetsuya Okano;
    • Satoshi Morita;
    • Kotone Matsuyama;
    • Kunihiko Kobayashi;
    • Masahiro Seike
    Publication type:
    Article
    12

    Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung C ancer: Analysis of Safety and Efficacy for Patients With Renal Impairment.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 7, p. 585, doi. 10.1016/j.cllc.2022.08.011
    By:
    • Yasuto Yoneshima;
    • Satoshi Morita;
    • Masahiko Ando;
    • Atsushi Nakamura;
    • Shunichiro Iwasawa;
    • Hiroshige Yoshioka;
    • Yasuhiro Goto;
    • Masafumi Takeshita;
    • Toshiyuki Harada;
    • Katsuya Hirano;
    • Tetsuya Oguri;
    • Masashi Kondo;
    • Satoru Miura;
    • Yukio Hosomi;
    • Terufumi Kato;
    • Toshio Kubo;
    • Junji Kishimoto;
    • Nobuyuki Yamamoto;
    • Yoichi Nakanishi;
    • Isamu Okamoto
    Publication type:
    Article
    13
    14

    Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non—Small-Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2017, v. 18, n. 1, p. 100, doi. 10.1016/j.cllc.2016.08.003
    By:
    • Yasuto Yoneshima;
    • Satoshi Morita;
    • Masahiko Ando;
    • Satoru Miura;
    • Hiroshige Yoshioka;
    • Tetsuya Abe;
    • Terufumi Kato;
    • Masashi Kondo;
    • Yukio Hosomi;
    • Katsuyuki Hotta;
    • Nobuyuki Yamamoto;
    • Junji Kishimoto;
    • Yoichi Nakanishi;
    • Isamu Okamoto
    Publication type:
    Article
    15
    16
    17
    18
    19

    Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017.

    Published in:
    Molecular & Clinical Oncology, 2019, v. 11, n. 4, p. 349, doi. 10.3892/mco.2019.1903
    By:
    • Nakahara, Yoshiro;
    • Hosomi, Yukio;
    • Shibuya, Masahiko;
    • Mitsufuji, Hisashi;
    • Katagiri, Masato;
    • Naoki, Katsuhiko;
    • Soejima, Kenzo;
    • Nogami, Naoyuki;
    • Nagase, Seisuke;
    • Nishikawa, Masanori;
    • Minato, Koichi;
    • Takiguchi, Yuichi;
    • Seki, Nobuhiko;
    • Yamada, Kouzo;
    • Seto, Takashi;
    • Okamoto, Hiroaki
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014.

    Published in:
    2015
    By:
    • Takagi, Yusuke;
    • Hosomi, Yukio;
    • Oshita, Fumihiro;
    • Okamoto, Hiroaki;
    • Seki, Nobuhiko;
    • Minato, Koichi;
    • Aono, Hiromi;
    • Yamada, Kouzo;
    • Okuma, Yusuke;
    • Hida, Naoya;
    • Sakamoto, Takahiko;
    • Miura, Yosuke;
    • Yomota, Makiko;
    • Satoh, Akira;
    • Kunitoh, Hideo;
    • Sakamaki, Kentaro;
    • Shibuya, Masahiko;
    • Watanabe, Koshiro
    Publication type:
    journal article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    A case of diffuse pulmonary ossification.

    Published in:
    Respirology Case Reports, 2021, v. 9, n. 8, p. 1, doi. 10.1002/rcr2.812
    By:
    • Yomota, Makiko;
    • Kamei, Tina;
    • Mirokuji, Kie;
    • Hishima, Tsunekazu;
    • Hosomi, Yukio
    Publication type:
    Article
    48
    49
    50